The shortage follows a sharp increase in reports of depression and anxiety in the U.S.
A spike in demand for anxiety and depression drugs has led to shortages of some forms of the commonly used antidepressant Zoloft and its generic, sertraline.
The same shortages were reported among companies that make sertraline. Accord Healthcare, Inc. said it's unable to obtain the active ingredient for the drug"due to the impacts caused by COVID-19." The company estimated the shortage will last 60 days. The shortages follow a 21 percent rise in the number of prescriptions filled per week between mid-February and mid-March for medicines to treat anxiety, depression and insomnia, according to Express Scripts, a prescription benefit plan provider. The company said the increase peaked the week of March 15, just after the World Health Organization declared COVID-19 a pandemic.
Story continuesThe survey, which included responses from 1,468 adults, found 13.6 percent reported psychological distress in April 2020, up from 3.9 percent surveyed in 2018.The increase was most notable among Hispanics, adults under age 30 and people in low-income households.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
‘You could see the train wreck coming’: Inexperienced, dubious companies among many aiming to cash in on coronavirus antibody testsBuyer beware? Coronavirus antibody tests approved for sale by the FDA include companies with little or no background in medical testing. One sells vape pens, another male enhancement powders.
Consulte Mais informação »
Hype and science collide as FDA tries to rein in 'wild West' of COVID-19 blood testsThe FDA is trying to rein in the chaos it created by allowing companies to flood the market with COVID-19 antibody tests of questionable accuracy.
Consulte Mais informação »
At-Home SAT Off the Table for This Year, College Board SaysThe College Board said it won’t pursue plans to offer an at-home version of the SAT this year and warned in-person test dates are already filling up, complicating its efforts to make the exam accessible to rising high school seniors.
Consulte Mais informação »